Why the study?
SERCA2a superinhibition is widely assumed to cause PLN-R14del-associated cardiomyopathy, but alternative mechanisms like abnormal energy metabolism are reported. This study evaluated Ca2+ dynamics and energy metabolism prior to cardiomyopathy development.
Population
Ventricular myocytes of 8-12 weeks-old, phenotypically silent, TG mice
Comparison
PLN R14del +/- mutation effects vs pharmacological PLN antagonism
Design
Preclinical transgenic mouse study
Key result
The PLN R14del+/- mutation resulted in hyperdynamic Ca2+ handling, including a 43% reduction in Ca2+ transient decay kinetics, indicating a loss of SERCA2a inhibition rather than superinhibition.
Authors
Loading...
Challenges superinhibition hypothesis in young PLN R14del mice; leaves open ER stress or SR-mito uncoupling as early ACM drivers in patients.
Effect estimate: 43% reduction
Absolute Event Rate: 284% vs 495%
p-value: p=<0.0001
The PLN R14del+/- mutation causes hyperdynamic Ca2+ handling and depressed resting energy metabolism prior to cardiomyopathy development, challenging the prevailing SERCA2a superinhibition hypothesis.
Maniezzi et al. (2023) studied Arrhythmogenic cardiomyopathy. PLN R14del+/- mutation vs. Wild-type (WT) littermates was evaluated on Ca2+ transient decay kinetics (τ decay) (43% reduction, p=<0.0001). The PLN R14del+/- mutation resulted in hyperdynamic Ca2+ handling, including a 43% reduction in Ca2+ transient decay kinetics, indicating a loss of SERCA2a inhibition rather than superinhibition.